Stoke Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Stoke Therapeutics's balance sheet done over the years? Its assets were worth $228,342,000 last year, which is less than in the previous period. 30% of Stoke Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $68,777,000, which means an decrease by -3% compared compared to last year.

Debt to Assets

Stoke Therapeutics, Inc. (NASDAQ:STOK): Debt to assets
2017 2439000 3.73M 152.97%
2018 107539000 2.47M 2.3%
2019 228750000 4.32M 1.89%
2020 297925000 11.84M 3.98%
2021 238865000 21.08M 8.83%
2022 256067000 71.21M 27.81%
2023 228342000 68.77M 30.12%

STOK Balance Sheet (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Assets
Current assets:
Cash and cash equivalents
191.44M113.55M144.89M287.30M222.47M105.39M1.79M
Short term investments
9.95M116.03M74.91M0000
Net receivables
64K588K132K6K281K196K0
Inventory
010.93M00000
Other current assets
13.88M2.95M9.27M6.61M3.28M548K113K
Total current assets
215.33M244.07M229.21M293.93M226.03M106.14M1.91M
Non-current assets:
Property, Plant and Equipment
12.43M11.42M9.07M3.79M2.51M1.19M473K
Goodwill
0000000
Intangible assets
0000000
Long term investments
0569K569K205K205K056K
Other non-current assets
569K0000204K0
Total non-current assets
13.00M11.99M9.64M3.99M2.71M1.39M529K
Total assets
228.34M256.06M238.86M297.92M228.75M107.53M2.43M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
15.30M14.88M12.70M-1.06M00-3M
Short term debt
2.38M2.35M1.50M1.06M003M
Total current liabilities
30.81M31.39M17.13M11.42M4.10M2.46M3.71M
Non-current liabilities:
Long term debt
02.71M3.53M80K000
Deferred tax
0000000
Other non-current liabilities
4.88M2.96M417K342K221K4K16K
Total non-current liabilities
37.95M39.82M3.94M422K221K4K16K
Total liabilities
68.77M71.21M21.08M11.84M4.32M2.47M3.73M
Data sourceData sourceData sourceData sourceData source